{"id":2044601,"date":"2026-07-15T12:55:20","date_gmt":"2026-07-15T09:55:20","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=2044601"},"modified":"2026-07-15T12:55:20","modified_gmt":"2026-07-15T09:55:20","slug":"premiera-in-lupta-impotriva-ebola-oms-testeaza-primul-antiviral-pentru-tulpina-bundibugyo","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=2044601","title":{"rendered":"Premier\u0103 \u00een lupta \u00eempotriva Ebola. OMS testeaz\u0103 primul antiviral pentru tulpina Bundibugyo"},"content":{"rendered":"

[analyse_image type=”featured” src=”https:\/\/www.tion.ro\/wp-content\/uploads\/2026\/07\/+otf\/1200×630\/IwKf2+ByPrzfph2IaKj16k5PVF9WRVJZX1NFQ2wRHDa06W0N5D0qY2q9WZyBq2ifhztclNHOM4m__yrzsD9ri44VwDrUj11UkpuH3sHxRgfuJ64gY6d5Bx9VbweI=\/412009414147700-scaled.jpg”]<\/p>\n

\n
\n
\n

Studiul, denumit EBO-PEP, urm\u0103re\u0219te s\u0103 evalueze eficien\u021ba tratamentului antiviral obeldesivir administrat persoanelor care au intrat \u00een contact cu pacien\u021bi confirma\u021bi cu aceast\u0103 variant\u0103 a virusului. Medicamentul, dezvoltat de compania american\u0103 Gilead Sciences, este administrat pe cale oral\u0103 \u0219i a demonstrat rezultate promi\u021b\u0103toare \u00een testele preclinice.<\/p>\n

Directorul general al OMS, Tedros Adhanom Ghebreyesus, a salutat lansarea studiului, subliniind importan\u021ba acestuia \u00een combaterea epidemiei.<\/p>\n

\n

\u201eFiecare descoperire \u00eencepe cu speran\u021b\u0103. Dac\u0103 acest tratament se dovede\u0219te eficient \u00een cazul persoanelor cu risc ridicat dup\u0103 expunere, ar putea reprezenta un progres major\u201d, a transmis acesta.<\/p>\n<\/blockquote>\n

Peste 700 de decese \u00een actuala epidemie<\/strong><\/h3>\n

\u00cen prezent, nu exist\u0103 un vaccin sau un tratament aprobat pentru varianta Bundibugyo a virusului Ebola. Potrivit autorit\u0103\u021bilor sanitare din Republica Democrat\u0103 Congo, aceast\u0103 tulpin\u0103 a infectat peste 1.960 de persoane \u0219i a provocat mai mult de 700 de decese.<\/p>\n

Epidemia a fost declarat\u0103 \u00een 15 mai, dup\u0103 raportarea mai multor decese \u00een provincia Ituri, din nord-estul \u021b\u0103rii. De atunci, cazuri au fost confirmate \u00een cinci provincii din Republica Democrat\u0103 Congo \u0219i \u00een Uganda, \u00eens\u0103 peste 90% dintre \u00eemboln\u0103viri continu\u0103 s\u0103 fie \u00eenregistrate \u00een Ituri.<\/p>\n

OMS a avertizat mar\u021bi c\u0103 amploarea real\u0103 a epidemiei ar putea fi de dou\u0103 p\u00e2n\u0103 la patru ori mai mare dec\u00e2t indic\u0103 datele oficiale, ceea ce sugereaz\u0103 existen\u021ba unui num\u0103r semnificativ de cazuri neraportate.<\/p>\n

\n
\n
\n
\n
\n

Trimite articolul<\/h4>\n

X<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
0<\/span>Comentarii<\/span><\/div>\n<\/div>\n
\n
\n

Cancel reply<\/a><\/small><\/h3>\n

Your email address will not be published.<\/span>Required fields are marked *<\/span><\/span><\/p>\n


\n inca
\n 1000<\/span>
\n caractere ramase
\n <\/span><\/p>\n<\/div>\n<\/div>\n

\n

\n Citi\u021bi principiile noastre de moderare aici<\/a>!\n <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n

\n
\n

Studiul, denumit EBO-PEP, urm\u0103re\u0219te s\u0103 evalueze eficien\u021ba tratamentului antiviral obeldesivir administrat persoanelor care au intrat \u00een contact cu pacien\u021bi confirma\u021bi cu aceast\u0103 variant\u0103 a virusului. Medicamentul, dezvoltat de compania american\u0103 Gilead Sciences, este administrat pe cale oral\u0103 \u0219i a demonstrat rezultate promi\u021b\u0103toare \u00een testele preclinice.<\/p>\n

Directorul general al OMS, Tedros Adhanom Ghebreyesus, a salutat lansarea studiului, subliniind importan\u021ba acestuia \u00een combaterea epidemiei.<\/p>\n

\n

\u201eFiecare descoperire \u00eencepe cu speran\u021b\u0103. Dac\u0103 acest tratament se dovede\u0219te eficient \u00een cazul persoanelor cu risc ridicat dup\u0103 expunere, ar putea reprezenta un progres major\u201d, a transmis acesta.<\/p>\n<\/blockquote>\n

Peste 700 de decese \u00een actuala epidemie<\/strong><\/h3>\n

\u00cen prezent, nu exist\u0103 un vaccin sau un tratament aprobat pentru varianta Bundibugyo a virusului Ebola. Potrivit autorit\u0103\u021bilor sanitare din Republica Democrat\u0103 Congo, aceast\u0103 tulpin\u0103 a infectat peste 1.960 de persoane \u0219i a provocat mai mult de 700 de decese.<\/p>\n

Epidemia a fost declarat\u0103 \u00een 15 mai, dup\u0103 raportarea mai multor decese \u00een provincia Ituri, din nord-estul \u021b\u0103rii. De atunci, cazuri au fost confirmate \u00een cinci provincii din Republica Democrat\u0103 Congo \u0219i \u00een Uganda, \u00eens\u0103 peste 90% dintre \u00eemboln\u0103viri continu\u0103 s\u0103 fie \u00eenregistrate \u00een Ituri.<\/p>\n

OMS a avertizat mar\u021bi c\u0103 amploarea real\u0103 a epidemiei ar putea fi de dou\u0103 p\u00e2n\u0103 la patru ori mai mare dec\u00e2t indic\u0103 datele oficiale, ceea ce sugereaz\u0103 existen\u021ba unui num\u0103r semnificativ de cazuri neraportate.<\/p>\n

\n
\n
\n
\n
\n

Trimite articolul<\/h4>\n

X<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
0<\/span>Comentarii<\/span><\/div>\n<\/div>\n
\n
\n

Cancel reply<\/a><\/small><\/h3>\n

Your email address will not be published.<\/span>Required fields are marked *<\/span><\/span><\/p>\n


\n inca
\n 1000<\/span>
\n caractere ramase
\n <\/span><\/p>\n<\/div>\n<\/div>\n

\n

\n Citi\u021bi principiile noastre de moderare aici<\/a>!\n <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[analyse_source url=”https:\/\/www.tion.ro\/mapamond\/premiera-in-lupta-impotriva-ebola-oms-testeaza-primul-antiviral-pentru-tulpina-bundibugyo-2316624\/”]<\/p>\n","protected":false},"excerpt":{"rendered":"

[analyse_image type=”featured” src=”https:\/\/www.tion.ro\/wp-content\/uploads\/2026\/07\/+otf\/1200×630\/IwKf2+ByPrzfph2IaKj16k5PVF9WRVJZX1NFQ2wRHDa06W0N5D0qY2q9WZyBq2ifhztclNHOM4m__yrzsD9ri44VwDrUj11UkpuH3sHxRgfuJ64gY6d5Bx9VbweI=\/412009414147700-scaled.jpg”] Studiul, denumit EBO-PEP, urm\u0103re\u0219te s\u0103 evalueze eficien\u021ba tratamentului antiviral obeldesivir administrat persoanelor care au intrat \u00een contact cu pacien\u021bi confirma\u021bi cu aceast\u0103 variant\u0103 a virusului. Medicamentul, dezvoltat de compania american\u0103 Gilead Sciences, este administrat pe cale oral\u0103 \u0219i a demonstrat rezultate promi\u021b\u0103toare \u00een testele preclinice. Directorul general al OMS, Tedros Adhanom Ghebreyesus, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[89],"tags":[226,191],"class_list":["post-2044601","post","type-post","status-publish","format-standard","hentry","category-romania","tag-crawlmanager","tag-tion-ro"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2044601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2044601"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2044601\/revisions"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2044601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2044601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2044601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}